A detailed history of Wedbush Securities Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wedbush Securities Inc holds 90,034 shares of ABBV stock, worth $15.8 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
90,034
Previous 101,793 11.55%
Holding current value
$15.8 Million
Previous $17.5 Million 1.83%
% of portfolio
0.66%
Previous 0.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $1.93 Million - $2.34 Million
-11,759 Reduced 11.55%
90,034 $17.8 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $644,700 - $752,865
4,165 Added 4.27%
101,793 $17.5 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $716,632 - $816,536
4,484 Added 4.81%
97,628 $17.8 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $684,972 - $771,440
-4,978 Reduced 5.07%
93,144 $14.4 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $328,364 - $380,129
2,458 Added 2.57%
98,122 $14.6 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $2.28 Million - $2.84 Million
-17,229 Reduced 15.26%
95,664 $12.9 Million
Q1 2023

May 09, 2023

SELL
$144.61 - $166.54 $24,583 - $28,311
-170 Reduced 0.15%
112,893 $18 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $111,339 - $133,525
805 Added 0.72%
113,063 $18.3 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $277,546 - $318,327
2,068 Added 1.88%
112,258 $15.1 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $243,449 - $309,504
-1,769 Reduced 1.58%
110,190 $16.9 Million
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $712,823 - $884,413
-5,401 Reduced 4.6%
111,959 $18.1 Million
Q4 2021

Jan 13, 2022

BUY
$107.43 - $135.93 $227,214 - $287,491
2,115 Added 1.84%
117,360 $15.9 Million
Q3 2021

Oct 08, 2021

BUY
$106.4 - $120.78 $309,730 - $351,590
2,911 Added 2.59%
115,245 $12.4 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $137,088 - $152,724
1,303 Added 1.17%
112,334 $12.7 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $1.48 Million - $1.63 Million
14,438 Added 14.95%
111,031 $12 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $465,312 - $628,221
5,781 Added 6.37%
96,593 $10.4 Million
Q3 2020

Oct 20, 2020

BUY
$85.91 - $100.83 $107,559 - $126,239
1,252 Added 1.4%
90,812 $7.95 Million
Q2 2020

Jul 16, 2020

BUY
$73.37 - $98.18 $862,390 - $1.15 Million
11,754 Added 15.11%
89,560 $8.79 Million
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $73,723 - $111,773
1,143 Added 1.49%
77,806 $5.93 Million
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $188,619 - $236,003
2,615 Added 3.53%
76,663 $6.79 Million
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $641,325 - $771,056
10,183 Added 15.94%
74,048 $5.61 Million
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $203,670 - $260,338
3,100 Added 5.1%
63,865 $4.64 Million
Q1 2019

Apr 17, 2019

SELL
$77.14 - $90.79 $920,820 - $1.08 Million
-11,937 Reduced 16.42%
60,765 $4.9 Million
Q4 2018

Jan 31, 2019

BUY
$77.85 - $96.01 $179,055 - $220,823
2,300 Added 3.27%
72,702 $6.7 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $69,527 - $77,292
782 Added 1.12%
70,402 $6.66 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $355,528 - $420,670
3,960 Added 6.03%
69,620 $6.45 Million
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $48,673 - $65,178
-529 Reduced 0.8%
65,660 $6.22 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $715,047 - $784,108
-7,984 Reduced 10.76%
66,189 $6.4 Million
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $5.18 Million - $6.62 Million
74,173
74,173 $6.59 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.